Last 7 days
10%
Last 30 days
34.6%
Last 90 days
-35.6%
Trailing 12 Months
-31.1%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 770.4M | 818.7M | 798.2M | 0 |
2022 | 569.4M | 618.2M | 696.6M | 698.8M |
2021 | 430.4M | 471.9M | 492.2M | 538.6M |
2020 | 321.7M | 311.4M | 358.4M | 380.8M |
2019 | 261.8M | 278.5M | 296.4M | 307.0M |
2018 | 203.7M | 224.5M | 236.3M | 264.2M |
2017 | 90.3M | 122.5M | 141.3M | 174.1M |
2016 | 48.2M | 57.0M | 70.2M | 82.7M |
2015 | 23.5M | 28.6M | 36.7M | 36.8M |
2014 | 36.8M | 31.6M | 17.0M | 25.2M |
2013 | 28.6M | 27.8M | 36.9M | 34.7M |
2012 | 113.1M | 115.9M | 36.7M | 33.9M |
2011 | 0 | 0 | 0 | 105.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Sep 06, 2023 | young alethia | sold | -464,972 | 39.857 | -11,666 | - |
Sep 06, 2023 | young alethia | acquired | 324,898 | 27.85 | 11,666 | - |
Jul 13, 2023 | gravier pierre | acquired | - | - | 26,000 | chief financial officer |
Jun 07, 2023 | schmertzler michael | sold | -44,860 | 44.86 | -1,000 | - |
Jun 06, 2023 | bell william f. jr. | acquired | - | - | 6,333 | - |
May 23, 2023 | reeve emma | sold | -157,885 | 59.5342 | -2,652 | - |
May 23, 2023 | reeve emma | acquired | 88,520 | 33.3786 | 2,652 | - |
May 22, 2023 | reeve emma | acquired | 237,484 | 33.3733 | 7,116 | - |
May 22, 2023 | reeve emma | sold | -423,630 | 59.5321 | -7,116 | - |
May 22, 2023 | pauwels eric | sold | -118,791 | 59.0122 | -2,013 | chief business officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 07, 2023 | Hudson Bay Capital Management LP | new | - | 1,344,600 | 1,344,600 | -% |
Dec 06, 2023 | CITIGROUP INC | added | 129 | 968,281 | 4,641,510 | -% |
Nov 30, 2023 | Neo Ivy Capital Management | added | 2,437 | 245,000 | 264,000 | 0.12% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 15.88 | -474,185 | 837,708 | -% |
Nov 22, 2023 | Graham Capital Management, L.P. | sold off | -100 | -614,239 | - | -% |
Nov 21, 2023 | Walleye Capital LLC | added | 958 | 1,337,470 | 1,614,190 | -% |
Nov 21, 2023 | COMERICA BANK | new | - | 7,059 | 7,059 | -% |
Nov 17, 2023 | JACOBS LEVY EQUITY MANAGEMENT, INC | added | 10.21 | -16,269,800 | 25,159,700 | 0.15% |
Nov 17, 2023 | Diversified Trust Co | added | 2.45 | -230,071 | 298,232 | 0.01% |
Nov 17, 2023 | TimesSquare Capital Management, LLC | sold off | -100 | -23,278,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Nov 13, 2023 | fmr llc | - | 0 | SC 13G/A | |
Oct 30, 2023 | camber capital management lp | 5.31% | 2,013 | SC 13G | |
Feb 14, 2023 | rtw investments, lp | 7.7% | 5,615,387 | SC 13G/A | |
Feb 09, 2023 | janus henderson group plc | 2.8% | 2,027,142 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 10.21% | 7,339,520 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 10.34% | 7,430,907 | SC 13G/A | |
Feb 01, 2023 | franklin resources inc | 4.8% | 3,489,687 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 9.2% | 6,640,854 | SC 13G/A | |
Jul 11, 2022 | vanguard group inc | 10.07% | 7,183,692 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 13, 2023 | SC 13G/A | Major Ownership Report | |
Nov 07, 2023 | POSASR | POSASR | |
Oct 30, 2023 | SC 13G | Major Ownership Report | |
Oct 26, 2023 | 8-K | Current Report | |
Oct 26, 2023 | 10-Q | Quarterly Report | |
Oct 19, 2023 | 8-K | Current Report | |
Oct 19, 2023 | 8-K | Current Report | |
Sep 28, 2023 | 8-K | Current Report | |
Sep 22, 2023 | 8-K | Current Report | |
Sep 15, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HILS | 31.5B | - | 6.13% | 411799.31% | -3.7K | 218.4K | - | -102.45% |
MRNA | 30.6B | 10.7B | 12.59% | -56.51% | -8.83 | 2.87 | -53.67% | -129.46% |
ALNY | 21.3B | 1.7B | 0.38% | -28.56% | -41.84 | 12.38 | 79.37% | 56.87% |
BMRN | 17.5B | 2.3B | 8.71% | -10.95% | 119.09 | 7.58 | 15.05% | 75.21% |
INCY | 12.3B | 3.6B | 1.18% | -34.97% | 28.84 | 3.4 | 8.35% | -51.49% |
MID-CAP | ||||||||
APLS | 7.4B | 272.9M | 33.62% | 24.68% | -12.26 | 27.23 | 141.38% | 4.43% |
BBIO | 5.7B | - | 10.65% | 240.88% | -9.69 | 48.33 | 54.84% | -12.96% |
ACAD | 3.4B | 631.9M | -9.53% | 43.40% | -23.12 | 5.44 | 23.54% | 31.53% |
AXSM | 3.3B | 223.4M | 14.00% | -9.85% | -16.45 | 14.86 | - | -26.24% |
ARWR | 2.6B | 240.7M | -11.63% | -24.14% | -12.52 | 10.67 | -1.03% | -16.59% |
SMALL-CAP | ||||||||
CPRX | 1.5B | 348.4M | 12.92% | -15.71% | 24.33 | 4.33 | 81.69% | -7.29% |
NVAX | 661.3M | 1.0B | -18.09% | -67.84% | -1.2 | 0.63 | -43.15% | 58.48% |
INO | 100.5M | 6.4M | - | -79.35% | -0.61 | 15.6 | -44.11% | 50.48% |
IBIO | 37.6M | - | 385.71% | 119.35% | -0.58 | - | - | -29.23% |
CRBP | 23.7M | - | 40.31% | 4064.72% | -0.5 | - | - | -13.74% |
Income Statement (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | -8.1% | 196,576,000 | 213,808,000 | 220,382,000 | 167,412,500 | 217,127,000 | 165,526,000 | 148,735,000 | 165,230,500 | 138,743,000 | 116,676,000 | 117,942,000 | 118,864,000 | 118,404,000 | 75,239,000 | 68,259,000 | 96,459,000 | 71,416,000 | 85,522,000 | 53,583,000 | 85,833,000 | 53,591,000 |
Operating Expenses | -25.7% | 314,740,000 | 423,351,000 | 337,997,000 | 367,752,000 | 285,314,000 | 257,888,000 | 235,257,000 | 249,958,500 | 231,819,000 | 215,169,000 | 216,090,000 | 215,238,000 | 173,535,000 | 262,512,000 | 161,250,000 | 169,243,000 | 131,891,000 | 124,280,000 | 122,723,000 | 131,476,000 | 101,821,000 |
S&GA Expenses | -8.6% | 80,886,000 | 88,449,000 | 86,914,000 | 92,717,500 | 80,118,000 | 79,892,000 | 73,271,000 | 86,548,000 | 69,252,000 | 68,878,000 | 61,095,000 | 75,456,000 | 57,840,000 | 53,659,000 | 58,209,000 | 63,497,500 | 49,284,000 | 49,215,000 | 40,544,000 | 48,666,000 | 38,368,000 |
R&D Expenses | -11.7% | 164,212,000 | 185,874,000 | 195,124,000 | 188,693,500 | 165,462,000 | 157,263,000 | 140,078,000 | 149,844,000 | 130,845,000 | 125,482,000 | 134,513,000 | 118,013,000 | 92,998,000 | 176,525,000 | 90,107,000 | 81,831,000 | 63,076,000 | 59,979,000 | 52,566,000 | 53,646,500 | 54,368,000 |
EBITDA Margin | - | - | - | -0.56 | -0.63 | -0.60 | -0.71 | -0.75 | -0.83 | -0.76 | -0.62 | -0.84 | -0.92 | -0.99 | -1.20 | -0.73 | -0.65 | - | - | - | - | - |
Interest Expenses | 25.2% | 11,710,000 | 9,354,000 | 12,956,000 | 5,784,000 | 4,406,000 | 2,143,000 | 6,130,000 | -1,000 | 4,407,000 | - | 5,182,000 | - | 4,516,000 | 408,000 | 4,878,000 | 651,000 | 3,931,000 | - | 3,111,000 | 846,000 | 3,089,000 |
Income Taxes | 12.9% | -33,620,000 | -38,596,000 | 3,969,000 | -18,804,000 | -17,893,000 | 3,392,000 | 4,835,000 | 4,657,500 | -36,000 | 488,000 | 451,000 | 12,634,000 | 22,288,000 | 84,000 | 222,000 | 10,644,000 | -344,000 | 774,000 | 576,000 | -993,500 | 355,000 |
Earnings Before Taxes | 29.9% | -166,590,000 | -237,479,000 | -134,990,000 | -189,693,000 | -127,208,000 | -148,695,000 | -121,891,000 | -138,607,500 | -133,660,000 | -117,882,000 | -128,191,000 | -61,720,000 | -47,404,000 | -181,343,000 | -112,465,000 | -67,033,000 | -60,341,000 | -41,015,000 | -71,537,000 | -49,323,000 | -50,614,000 |
EBT Margin | - | - | - | -0.78 | -0.84 | -0.77 | -0.88 | -0.90 | -0.96 | -0.90 | -0.75 | -0.97 | -1.06 | -1.14 | -1.35 | -0.87 | -0.78 | - | - | - | - | - |
Net Income | 33.1% | -132,970,000 | -198,883,000 | -138,959,000 | -170,889,000 | -109,315,000 | -152,087,000 | -126,726,000 | -143,265,000 | -133,624,000 | -118,370,000 | -128,642,000 | -74,354,000 | -69,692,000 | -181,427,000 | -112,687,000 | -77,677,000 | -59,997,000 | -41,789,000 | -72,113,000 | -48,330,000 | -50,969,000 |
Net Income Margin | - | - | - | -0.74 | -0.80 | -0.76 | -0.90 | -0.92 | -0.97 | -0.92 | -0.83 | -1.05 | -1.15 | -1.23 | -1.39 | -0.91 | -0.82 | - | - | - | - | - |
Free Cashflow | - | - | - | -39,761,000 | -174,585,000 | -43,427,000 | -63,942,000 | -106,716,000 | -77,566,000 | -57,034,000 | -39,119,000 | -105,826,000 | -70,718,000 | 23,351,000 | -76,970,000 | -87,577,000 | -14,859,000 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | -5.8% | 1,260 | 1,338 | 1,609 | 1,706 | 1,576 | 1,804 | 1,800 | 1,938 | 2,007 | 2,059 | 2,112 | 2,208 | 2,181 | 1,477 | 1,546 | 1,624 | 1,641 | 1,292 | 1,284 | 1,119 | 1,029 |
Current Assets | -8.4% | 540 | 590 | 613 | 694 | 517 | 695 | 774 | 954 | 1,011 | 1,066 | 1,122 | 1,232 | 1,244 | 605 | 692 | 779 | 807 | 475 | 479 | 321 | 313 |
Cash Equivalents | -20.7% | 165 | 208 | 167 | 280 | 121 | 174 | 152 | 197 | 197 | 185 | 154 | 216 | 441 | 166 | 131 | 296 | 531 | 136 | 201 | 169 | 207 |
Inventory | 11.7% | 36.00 | 32.00 | 27.00 | 22.00 | 15.00 | 15.00 | 15.00 | 16.00 | 16.00 | 16.00 | 16.00 | 19.00 | 19.00 | 18.00 | 19.00 | 19.00 | 17.00 | 17.00 | 16.00 | 16.00 | 14.00 |
Net PPE | 3.5% | 85.00 | 82.00 | 79.00 | 73.00 | 67.00 | 65.00 | 59.00 | 53.00 | 46.00 | 43.00 | 37.00 | 34.00 | 28.00 | 27.00 | 26.00 | 22.00 | 18.00 | 15.00 | 15.00 | 13.00 | 9.00 |
Goodwill | 0% | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 82.00 | 100 |
Liabilities | 0.7% | 1,931 | 1,917 | 2,066 | 2,053 | 1,803 | 1,986 | 1,890 | 1,937 | 1,902 | 1,862 | 1,819 | 1,726 | 1,670 | 904 | 1,017 | 1,029 | 978 | 803 | 771 | 768 | 643 |
Current Liabilities | 3.3% | 492 | 476 | 442 | 406 | 420 | 567 | 477 | 509 | 465 | 291 | 251 | 277 | 254 | 202 | 218 | 236 | 184 | 174 | 143 | 167 | 115 |
LT Debt, Current | - | - | - | - | - | - | 150 | 150 | 150 | 149 | - | - | - | - | 18.00 | 20.00 | 20.00 | 20.00 | 20.00 | 17.00 | 12.00 | 7.00 |
LT Debt, Non Current | 0.1% | 573 | 573 | 572 | 572 | 283 | 282 | 282 | 282 | 282 | 430 | 430 | 309 | 303 | 297 | 295 | 294 | 293 | 136 | 138 | 141 | 144 |
Shareholder's Equity | -15.8% | -670 | -579 | - | -347 | -226 | -182 | - | 1.00 | 105 | 197 | 293 | 482 | 511 | 572 | 529 | 594 | 664 | 489 | 513 | 351 | 386 |
Retained Earnings | -4.4% | -3,127 | -2,994 | -2,795 | -2,656 | -2,486 | -2,376 | -2,224 | -2,097 | -1,954 | -1,821 | -1,702 | -1,628 | -1,554 | -1,484 | -1,303 | -1,190 | -1,112 | -1,052 | -1,011 | -938 | -890 |
Additional Paid-In Capital | 1.3% | 2,447 | 2,417 | 2,340 | 2,305 | 2,223 | 2,184 | 2,153 | 2,124 | 2,093 | 2,064 | 2,034 | 2,172 | 2,101 | 2,067 | 1,834 | 1,795 | 1,776 | 1,540 | 1,523 | 1,288 | 1,275 |
Shares Outstanding | 0.2% | 75.00 | 75.00 | 74.00 | 73.00 | 72.00 | 71.00 | 71.00 | 71.00 | 71.00 | 70.00 | 70.00 | 70.00 | 68.00 | 64.00 | 62.00 | 62.00 | 58.00 | 57.00 | 56.00 | 47.00 | 45.00 |
Cashflow (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -2.8% | -14.52 | -14.12 | -29.49 | -165 | -38.04 | -55.24 | -97.40 | -68.84 | -51.19 | -31.14 | -100 | -64.37 | 27.00 | -74.81 | -81.55 | -10.21 | -15.50 | -30.52 | -42.41 | -15.14 | 3.00 |
Share Based Compensation | -8.3% | 27.00 | 29.00 | 29.00 | 27.00 | 29.00 | 28.00 | 27.00 | 26.00 | 26.00 | 26.00 | 26.00 | 21.00 | 17.00 | 17.00 | 15.00 | 11.00 | 10.00 | 11.00 | 9.00 | 8.00 | 9.00 |
Cashflow From Investing | -24.6% | -29.60 | -23.75 | -28.97 | 32.00 | 136 | 72.00 | 49.00 | 68.00 | 65.00 | 56.00 | 30.00 | -208 | -394 | 142 | -101 | -229 | 30.00 | -38.17 | -150 | -24.60 | -24.11 |
Cashflow From Financing | -81.8% | 3.00 | 18.00 | 4.00 | 303 | -139 | 4.00 | 1.00 | 4.00 | 3.00 | 4.00 | 10.00 | 40.00 | 643 | -32.92 | 18.00 | 2.00 | 382 | 3.00 | 226 | 4.00 | 5.00 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenues: | ||||
Revenue | $ 196,576 | $ 217,127 | $ 630,766 | $ 531,389 |
Operating expenses: | ||||
Cost of product sales, excluding amortization of acquired intangible assets | 9,493 | 14,011 | 36,368 | 33,785 |
Amortization of intangible assets | 58,649 | 31,023 | 145,461 | 80,790 |
Research and development | 164,212 | 165,462 | 545,210 | 462,802 |
Selling, general and administrative | 80,886 | 80,118 | 256,249 | 233,280 |
Change in the fair value of contingent consideration | 1,500 | (5,300) | (125,000) | (32,200) |
Intangible asset impairment | 217,800 | |||
Total operating expenses | 314,740 | 285,314 | 1,076,088 | 778,457 |
Loss from operations | (118,164) | (68,187) | (445,322) | (247,068) |
Interest expense, net | (28,160) | (20,880) | (84,905) | (66,371) |
Other expense, net | (20,266) | (38,141) | (8,832) | (84,355) |
Loss before income tax benefit | (166,590) | (127,208) | (539,059) | (397,794) |
Income tax benefit | 33,620 | 17,893 | 68,247 | 9,666 |
Net loss attributable to common stockholders | $ (132,970) | $ (109,315) | $ (470,812) | $ (388,128) |
Weighted-average shares outstanding: | ||||
Basic | 75,377,997 | 71,654,671 | 74,618,611 | 71,415,849 |
Diluted | 75,377,997 | 71,654,671 | 74,618,611 | 71,415,849 |
Net loss per share-basic and diluted (in dollars per share) | ||||
Basic | $ (1.76) | $ (1.53) | $ (6.31) | $ (5.43) |
Diluted | $ (1.76) | $ (1.53) | $ (6.31) | $ (5.43) |
Net product revenue | ||||
Revenues: | ||||
Revenue | $ 144,038 | $ 134,186 | $ 506,187 | $ 407,720 |
Collaboration revenue | ||||
Revenues: | ||||
Revenue | 0 | 50,017 | 6 | 50,024 |
Royalty revenue | ||||
Revenues: | ||||
Revenue | 50,173 | 32,924 | 117,857 | 73,645 |
Manufacturing revenue | ||||
Revenues: | ||||
Revenue | $ 2,365 | $ 0 | $ 6,716 | $ 0 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 165,157 | $ 279,834 |
Marketable securities | 129,653 | 130,871 |
Trade and royalty receivables, net | 165,718 | 155,614 |
Inventory, net | 35,752 | 21,808 |
Prepaid expenses and other current assets | 44,082 | 105,658 |
Total current assets | 540,362 | 693,785 |
Fixed assets, net | 85,031 | 72,590 |
Intangible assets, net | 423,342 | 705,891 |
Goodwill | 82,341 | 82,341 |
Operating lease ROU assets | 94,072 | 102,430 |
Deposits and other assets | 34,737 | 48,582 |
Total assets | 1,259,885 | 1,705,619 |
Current liabilities: | ||
Accounts payable and accrued expenses | 370,731 | 320,366 |
Deferred revenue | 1,224 | 1,351 |
Operating lease liabilities- current | 11,703 | 9,370 |
Finance lease liabilities- current | 2,611 | 3,000 |
Liability for sale of future royalties - current | 105,849 | 72,149 |
Total current liabilities | 492,118 | 406,236 |
Long-term debt | 573,174 | 571,722 |
Contingent consideration payable | 39,000 | 164,000 |
Deferred tax liability | 51,927 | 102,834 |
Operating lease liabilities- noncurrent | 99,682 | 100,860 |
Finance lease liabilities- noncurrent | 17,184 | 18,675 |
Liability for sale of future royalties- noncurrent | 657,469 | 685,737 |
Other long-term liabilities | 141 | 2,641 |
Total liabilities | 1,930,695 | 2,052,705 |
Stockholders' deficit: | ||
Common stock, $0.001 par value. Authorized 250,000,000 shares; issued and outstanding 75,459,022 shares at September 30, 2023. Authorized 250,000,000 shares; issued and outstanding 73,104,692 shares at December 31, 2022 | 75 | 72 |
Additional paid-in capital | 2,447,292 | 2,305,020 |
Accumulated other comprehensive income | 9,609 | 4,796 |
Accumulated deficit | (3,127,786) | (2,656,974) |
Total stockholders' deficit | (670,810) | (347,086) |
Total liabilities and stockholders' deficit | $ 1,259,885 | $ 1,705,619 |
CEO | Dr. Matthew B. Klein F.A.C.S., FACS, M.D., M.S., MS |
---|---|
WEBSITE | www.ptcbio.com |
EMPLOYEES | 1402 |